Evidence map›Paper›PMID 32990819›Full record

ArticleEJNMMI research2020

[

Verena Buchecker, Ann-Marie Waldron, R Maarten van Dijk, Ines Koska, Matthias Brendel, Barbara von Ungern-Sternberg, Simon Lindner, Franz Josef Gildehaus, Sibylle Ziegler, Peter Bartenstein and 1 more

Open access · goldAbstract read
In one paragraph

Article in EJNMMI research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Verena BucheckerInstitute of Pharmacology, Toxicology and Pharmacy, Ludwig-Maximilians-University, Königinstr. 16, 80539, Munich, Germany.
Ann-Marie WaldronInstitute of Pharmacology, Toxicology and Pharmacy, Ludwig-Maximilians-University, Königinstr. 16, 80539, Munich, Germany.
R Maarten van DijkInstitute of Pharmacology, Toxicology and Pharmacy, Ludwig-Maximilians-University, Königinstr. 16, 80539, Munich, Germany.
Ines KoskaInstitute of Pharmacology, Toxicology and Pharmacy, Ludwig-Maximilians-University, Königinstr. 16, 80539, Munich, Germany.
Matthias BrendelDepartment of Nuclear Medicine, University Hospital of Munich, Ludwig-Maximilians-University, Munich, Germany.
Barbara von Ungern-SternbergDepartment of Nuclear Medicine, University Hospital of Munich, Ludwig-Maximilians-University, Munich, Germany.
Simon LindnerDepartment of Nuclear Medicine, University Hospital of Munich, Ludwig-Maximilians-University, Munich, Germany.
Franz Josef GildehausDepartment of Nuclear Medicine, University Hospital of Munich, Ludwig-Maximilians-University, Munich, Germany.
Sibylle ZieglerDepartment of Nuclear Medicine, University Hospital of Munich, Ludwig-Maximilians-University, Munich, Germany.
Peter BartensteinDepartment of Nuclear Medicine, University Hospital of Munich, Ludwig-Maximilians-University, Munich, Germany.
Heidrun PotschkaInstitute of Pharmacology, Toxicology and Pharmacy, Ludwig-Maximilians-University, Königinstr. 16, 80539, Munich, Germany. potschka@pharmtox.vetmed.uni-muenchen.de.
Ludwig-Maximilians-Universität München · DE

Funding

Deutsche Forschungsgemeinschaft FOR 2591, GZ: PO681/9-1
6 · The paper itself

Abstract

backgroundStress exposure can significantly affect serotonergic signaling with a particular impact on 5-HT MATERIAL AND

methodsFor twelve consecutive days, Sprague Dawley rats were exposed to daily transport with a 1 h stay in a laboratory or daily transport plus 1 h restraint in a narrow tube. Following, animals were subjected to μPET imaging with 2'-methoxyphenyl-(N-2'-pyridinyl)-p-[

resultsIn rats with repeated transport, hippocampal [

conclusionsMild-to-moderate stress associated with daily transport and exposure to a laboratory environment can trigger significant alterations in hippocampal binding of the 5-HT

Indexed as

5-HT1A receptorAnimal modelBehaviorBrain glucose metabolismDistressMicro-PET

Identifiers

PMID32990819
PMCPMC7524912
OpenAlexW3089914381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.